This federal contract award, identified as SPE2DB20D1110|SPE2DB25FJ73S, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,546.86, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 5, 2024.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also includes a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
The contract award reviewed does not have a set-aside designation, indicating open competition.
Generated 2/3/25, 1:17 PM